Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Metabolic Adaptation of CD8⁺ T Cells Limits the Efficacy of Fatty Acid Oxidation Inhibition in Type 1 Diabetes.
PMID 41800251 · PMC12965062 · International journal of biological sciences · 2026 · 8 claims · 8 setups
TMZ enhances mitochondrial membrane potential and suppresses fatty acid oxidation (FAO) in human T cells
-
Full-text index only
Metabolic adaptations rewire CD4(+) T cells in a subset-specific manner in human critical illness with and without sepsis.
PMID 41540263 · PMC12864044 · Nature immunology · 2026 · 8 claims · 7 setups
CD4+ T cells in critical illness show subset-specific metabolic plasticity, with regulatory T (Treg) cells preferentially acquiring glycolytic capacity
-
Full-text index only
The ubiquitin ligase KLHL6 drives resistance to CD8(+) T cell dysfunction.
PMID 41535474 · PMC12979199 · Nature · 2026 · 8 claims · 8 setups
KLHL6 is a dual-negative regulator of both T cell exhaustion and mitochondrial dysfunction
-
Full-text index only
T cell-intrinsic VISTA expression promotes resistance to CTLA-4 blockade by restricting CD8+ T cell responses.
PMID 41837284 · PMC12987620 · The Journal of clinical investigation · 2026 · 8 claims · 8 setups
Loss of T cell-intrinsic VISTA enhances early priming and short-term expansion of CD8+ T cells but this initial advantage fails to confer durable tumor control
-
Full-text index only
Disruption of metabolic licensing by JAK inhibitors constrains CD8 T cell activation and effector function.
PMID 41876467 · PMC13039990 · Cell death & disease · 2026 · 8 claims · 8 setups
JAKis targeting JAK1, JAK1/2, or JAK1/3 markedly reduce CD8 T cell activation markers, proliferation, and effector molecule (TNF, granzyme B) production
-
Full-text index only
Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy.
PMID 41855504 · PMC13234471 · Blood advances · 2026 · 8 claims · 7 setups
LiP-Seq is a novel platform combining multiplexed live-cell imaging and needle-based single-cell retrieval that enables transcriptomic profiling of ultrarare (down to 10^-6 frequency), viable persistent lymphoma cells
-
Full-text index only
Update on diabetes mellitus.
PMID 15502249 · PMC3839330 · Disease markers · 2004 · 8 claims · 7 setups
Type 1 diabetes results from selective destruction of pancreatic beta cells via T-cell and cytokine mediated autoimmune mechanisms, possibly involving destruction of peri-islet Schwann cells.